
News|Articles|April 1, 2002
- Pharmaceutical Technology-04-02-2002
- Volume 26
- Issue 4
Outsourcing Outlook
Author(s)Jim Miller
The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.
Advertisement
Articles in this issue
almost 24 years ago
The Usefulness of 0.45 µm–Rated Filter Membranesalmost 24 years ago
Monitoring Blend Uniformity with Effusivityalmost 24 years ago
Bush Budget Combats Bioterrorism, Promotes Drug Safetyalmost 24 years ago
E-Procurement — Successfully Using and Managing Reverse Auctionsalmost 24 years ago
Liposomes: A ReviewNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
2
How a Government Shutdown Causes FDA Inspection Bottlenecks and Backlogs
3
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
4
Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine
5




